US 11938134
Metalloenzyme inhibitor compounds
granted A61KA61K31/506
Quick answer
US patent 11938134 (Metalloenzyme inhibitor compounds) held by Eikonizo Therapeutics, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eikonizo Therapeutics, Inc.
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/506